- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neurological Disorder
Total 163380 results
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
National Taiwan University HospitalCompletedAttention-deficit/Hyperactivity DisorderTaiwan
-
Hospital de Clinicas de Porto AlegreUnknownAttention Deficit/Hyperactivity DisorderBrazil
-
University Hospital, Strasbourg, FranceUnknownAttention Deficit and Hyperactivity DisorderFrance
-
Kimberley LakesShireCompletedAttention Deficit/Hyperactivity DisorderUnited States
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedAttention Deficit/Hyperactivity DisorderCanada
-
Novartis PharmaceuticalsCompletedAttention Deficit/Hyperactivity DisorderGermany, United States, Belgium, Colombia, Denmark, Sweden
-
Novartis PharmaceuticalsCompletedAttention Deficit/Hyperactivity DisorderUnited States, Germany, Singapore, Colombia, Sweden, Belgium, South Africa, Denmark, Norway
-
Janssen-Cilag International NVCompletedAttention Deficit/ Hyperactivity DisorderFrance, Belgium, Germany, Spain, Switzerland, Denmark, Finland, Netherlands, Norway, Sweden, United Kingdom
-
University of CologneShireUnknownAttention Deficit-/Hyperactivity DisorderGermany
-
National Taiwan University HospitalCompletedAttention-deficit/Hyperactivity DisorderTaiwan
-
CephalonCompletedADHD | Attention Deficit Hyperactivity DisorderUnited States
-
Universitaire Ziekenhuizen KU LeuvenUnknownAttention-deficit/Hyperactivity DisorderBelgium
-
Massachusetts General HospitalCompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderGermany
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderItaly
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderAustralia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Schizo Affective DisorderUnited States
-
University Hospital, MontpellierCompletedIntellectual Developmental Disorder | BCL11B Related DisorderFrance
-
Children's Hospital Medical Center, CincinnatiActive, not recruitingAttention Deficit Hyperactivity DisorderUnited States
-
Bambino Gesù Hospital and Research InstituteCompletedAttention Deficit Hyperactivity DisorderItaly
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Centre Hospitalier Universitaire, AmiensCompletedLanguage Development Disorders | Therapy | Speech and Language DisorderFrance
-
National Taiwan University HospitalCompletedAttention-deficit/Hyperactivity DisorderTaiwan
-
ShireCompletedAttention Deficit Hyperactivity DisorderSpain, United States, Germany, Poland, Italy, Ukraine, Romania, United Kingdom, Sweden, Austria, Canada, France, Ireland
-
ShireCompletedAttention-Deficit/Hyperactivity Disorder
-
Merck Sharp & Dohme LLCCompletedAttention Deficit Hyperactivity Disorder
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR)UnknownAttention Deficit Hyperactivity DisorderCanada
-
Hadassah Medical OrganizationCompletedAttention Deficit Hyperactivity DisorderIsrael
-
Wake Forest University Health SciencesCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Mensia Technologies SAEuropean Union H2020 SME InstrumentUnknownAttention Deficit-Hyperactivity DisorderFrance, Belgium, Germany, Spain, Switzerland
-
Indiana UniversityNational Library of Medicine (NLM)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Canada, Puerto Rico
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderKorea, Republic of, Taiwan, Japan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderAustralia, United Kingdom, Mexico
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Hartford HospitalYale UniversityCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderGermany
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderItaly, Spain, France, Belgium, Turkey, Ireland, Mexico, Norway, United Kingdom
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderJapan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderTaiwan
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited Kingdom
-
Peking UniversityRecruitingOutpatients / Inpatients With DepressionChina
-
Neurogen Brain and Spine InstituteWithdrawn
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCActive, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Massachusetts General HospitalShire Human Genetic Therapies, Inc.Active, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Ataturk UniversityCompletedAttention-deficit/Hyperactivity DisorderTurkey
-
Massachusetts General HospitalShireActive, not recruitingAttention Deficit/Hyperactivity DisorderUnited States